Skip to content
OpenCapital
Get started

Pagaya Technologies PGY Warrants And Rights Outstanding

Warrants And Rights Outstanding at other companies

OppFi logo
OppFiOPFI
$5.16M-85.9%

Other financials

Income statement

See full
Revenue$317.9M+9.6%
Gross profit$140.4M+14.2%
Operating income$80.0M+67.8%
Net income$24.7M+213%
EPS (diluted)$0.28+180%

Balance sheet

See full
Cash & equivalents$380.0M+65.5%
Total debt$507.6M+43.8%
Total equity$529.3M+57.8%
Total assets$1.6B+29.0%

Cash flow

See full
Operating cash flow$43.2M+25.4%
CapEx$3.2M-15.9%
Free cash flow$40.0M+30.5%

Valuation

See full
Market cap$1.26B-9.9%
Enterprise value$1.39B-8.8%
P/E12.8×—
P/S1×-0.4×

Profitability

See full
Gross margin42.9%+0.4pp
Operating margin22.3%+12.4pp
Net margin7.4%+4.0pp
FCF margin17.6%—

Returns & leverage

See full
Return on equity22.7%+12.8pp
Debt / equity1×-0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Pagaya Technologies in its filing.

Tagged under the XBRL concept us-gaap:WarrantsAndRightsOutstanding.

The official record: Pagaya Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pagaya Technologies's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pagaya Technologies's warrants and rights outstanding?
Pagaya Technologies (PGY) reported warrants and rights outstanding of $561K in Q1 2026.
How has Pagaya Technologies's warrants and rights outstanding changed year-over-year?
Pagaya Technologies's warrants and rights outstanding decreased by 71.8% year-over-year, from $1.99M to $561K.
What is the long-term trend for Pagaya Technologies's warrants and rights outstanding?
Over 5 years (2020 to 2025), Pagaya Technologies's warrants and rights outstanding has grown at a 13.8% compound annual growth rate (CAGR), from $2.47M to $4.72M.
What does warrants and rights outstanding mean?
This reflects the total value or count of derivative instruments that grant holders the right to purchase company equity at a specified price. These instruments represent potential future dilution for existing shareholders upon exercise. Tracking these outstanding rights is essential for calculating fully diluted share counts and understanding long-term capital structure impacts.